# Mubadala Capital

> Mubadala Capital is a VC fund in Dubai backing Biotechnology, Health Care and Software. See 29 investments, check sizes, portfolio. Updated Aug 2026.

- Type: VC Fund
- Location: Dubai, United Arab Emirates
- Total investments: 29
- Last investment: Jun 2026
- Lead investor: 34%
- Last updated: Aug 2026
- LinkedIn: https://www.linkedin.com/company/mubadala-capital
- X (Twitter): https://twitter.com/MubadalaCapital
- Website: https://www.mubadalacapital.ae

Mubadala Capital is an asset management firm.

## Investment focus

### Industry

| Industry | Investments | Share |
| --- | --- | --- |
| Biotechnology | 6 | 21% |
| Health Care | 4 | 14% |
| Software | 3 | 10% |
| Financial Services | 3 | 10% |
| Artificial Intelligence | 3 | 10% |

33 industries tracked in total.

### Stage

| Stage | Investments | Share |
| --- | --- | --- |
| Series B | 6 | 21% |
| Series A | 5 | 17% |
| Series C | 2 | 7% |
| Series D | 1 | 3% |
| Funding Round | 1 | 3% |

7 stages tracked in total.

### Country

| Country | Investments | Share |
| --- | --- | --- |
| United States | 13 | 45% |
| Canada | 1 | 3% |

## Investments

| Company | Description | Amount | Stage | Date | Website |
| --- | --- | --- | --- | --- | --- |
| Ollin Biosciences | Ollin Biosciences operates as a clinical-stage biopharmaceutical company dedicated to acquiring and developing best-in-disease therapies for vision-threatening diseases. | $330M | Series B | Jun 24, 2026 |  |
| Photonic | Photonic develops quantum computing and networking technologies, utilizing silicon spin qubits and native telecom networking interface. Photonic is turning fault-tolerant quantum technologies into reality through its distinctive silicon spin-photon interface. This innovative technology combines the memory and computing capabilities of spins withthe connectivity of photonics, enabling the creation of one of the world's initial scalable, fault-tolerant, and networked quantum computers. | $70M | Venture - Series Unknown | May 12, 2026 |  |
| Canada Cartage | Canada Cartage is a provider of outsourced fleet solutions, providing dedicated equipment and drivers to both small and large firms. Canada Cartage also provides integrated managed transportation and warehousing solutions, along with B2C home delivery of large format goods. | $400M | Debt Financing | May 06, 2026 |  |
| Salma Health | Salma Health is a concierge neurocognitive clinic that uses neurology and psychiatry techniques to solve various brain conditions. | $80M | Series A | Feb 26, 2026 |  |
| Salma Health | Salma Health is a concierge neurocognitive clinic that uses neurology and psychiatry techniques to solve various brain conditions. | $80M | Series A | Feb 26, 2026 |  |
| Waymo | Waymo stands for a new way forward in mobility. it is a self-driving technology company with a mission to make it safe and easy for people and things to move around.Waymo improves transportation by building software and sensor technology developed in Google’s labs since 2009. In October 2015, they achieved the world’s first fully self-drivingtrip on public roads, in a car without a steering wheel or pedals. They refine Waymo technology through one billion miles of simulation testing each year, and the cars have self-driven over two million miles on public roads across four U.S. cities.It was founded in 2009 and is located in Mountain View, California. | $16B | Series D | Feb 02, 2026 |  |
| AppliedAI | AAICO uses artificial intelligence to solve document, process, and measurable business improvement problems in regulated industries. |  | Series B | Jan 22, 2026 |  |
| Juvena Therapeutics | Juvena Therapeutics is a venture-backed biopharma startup discovering novel protein-based therapeutics that promote tissue regeneration in the elderly and treat various age-related diseases. | $33.5M | Series B | Jan 12, 2026 |  |
| Juvena Therapeutics | Juvena Therapeutics is a venture-backed biopharma startup discovering novel protein-based therapeutics that promote tissue regeneration in the elderly and treat various age-related diseases. | $33.5M | Series B | Jan 12, 2026 |  |
| Paradigm | Paradigm is rebuilding the clinical research ecosystem by developing a platform that allows all patients equitable access to trials while improving trial efficiency and lowering barriers to participation for healthcare providers. | $78M | Series B | Dec 04, 2025 |  |

10 of 29 investments shown.

## Co-investors
- [ARCH Venture Partners](https://shizune.co/investors/profile/arch-venture-partners) — VC Fund, 8 deals together
- [Alumni Ventures](https://shizune.co/investors/profile/alumni-ventures-group) — VC Fund, 5 deals together
- [General Catalyst](https://shizune.co/investors/profile/general-catalyst-partners) — VC Fund, 5 deals together
- [F-Prime](https://shizune.co/investors/profile/f-prime-capital-partners) — VC Fund, 4 deals together
- [Google Ventures](https://shizune.co/investors/profile/google-ventures) — VC Fund, 3 deals together
- [Qatar Investment Authority](https://shizune.co/investors/profile/qatar-investment-authority) — VC Fund, 3 deals together

## Similar investors

### Similar stage
- [Alumni Ventures](https://shizune.co/investors/profile/alumni-ventures-group) — VC Fund
- [General Catalyst](https://shizune.co/investors/profile/general-catalyst-partners) — VC Fund
- [FJ Labs](https://shizune.co/investors/profile/fj-labs) — VC Fund

## FAQ

### What does Mubadala Capital invest in?

Mubadala Capital invests primarily in Biotechnology, Health Care and Software startups, most often at Series B and Series A stage. Most of the 29 investments tracked by Shizune back companies in United States. The Investment Focus section breaks down every industry, stage and country in the portfolio.

### When did Mubadala Capital last invest?

The most recent investment recorded for Mubadala Capital closed in Jun 2026. Shizune tracks 29 investments in total for this profile, including round sizes, stages and portfolio companies, all sourced from confirmed public funding rounds and refreshed monthly.

### Is Shizune's investor data accurate?

Yes — every stat on this profile is calculated from confirmed public funding rounds monitored across hundreds of sources since 2020. This profile was last refreshed in Aug 2026 and is updated monthly. Spotted something off? Use the “Suggest an edit” link near the top of the page.

# About Shizune
Shizune.co is an investor database. Core features:
- 48,091 startup investors (angels, VCs, accelerators, and others)
- Email, phone, LinkedIn (for intros), socials, and other contact data
- Updated daily from public funding news
- CSV and Excel export

The User can access the full database FOR FREE after signing up: shizune.co